FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2016045856> ?p ?o ?g. }

• W2016045856 endingPage "1341" @default.
• W2016045856 startingPage "1335" @default.
• W2016045856 abstract "Background and purpose Pseudoprogression is a frequent phenomenon observed since the introduction of postoperative therapy with radiotherapy and temozolomide ( RT / TMZ ) in glioblastoma multiforme ( GBM ) patients. However, the criteria defining pseudoprogression, its incidence, the time of occurrence and its impact on therapy and outcome remain poorly defined. Methods The objective of this study is to compare two sets of criteria (liberal and stringent), defining pseudoprogression, in a cohort of patients treated before and after the introduction of RT / TMZ in the standard postoperative treatment. This retrospective review includes 136 unselected and consecutively treated patients with pathologically diagnosed GBM . Results Pseudoprogression was observed in 10 (12%) cases applying the stringent criteria, and in 18 (23%) patients when using the liberal criteria, in the cohort treated with RT / TMZ . Pseudoprogression was observed in only one patient treated with RT alone. The median time to pseudoprogression was 4 weeks after the end of RT. Patients with pseudoprogression had a median survival time of 28 months, compared with 12 months for patients without pseudoprogression. Conclusions The incidence of pseudoprogression after RT / TMZ strongly depends on the applied criteria. However, regardless of the stringency of the criteria, the impact on survival remains the same." @default.
• W2016045856 created "2016-06-24" @default.
• W2016045856 creator A5001037498 @default.
• W2016045856 creator A5004631664 @default.
• W2016045856 creator A5004669844 @default.
• W2016045856 creator A5005521408 @default.
• W2016045856 creator A5018786124 @default.
• W2016045856 creator A5023933895 @default.
• W2016045856 creator A5025936970 @default.
• W2016045856 creator A5039085121 @default.
• W2016045856 creator A5039346856 @default.
• W2016045856 creator A5048201812 @default.
• W2016045856 creator A5055506828 @default.
• W2016045856 creator A5086102127 @default.
• W2016045856 date "2013-05-17" @default.
• W2016045856 modified "2023-10-14" @default.
• W2016045856 title "Defining pseudoprogression in glioblastoma multiforme" @default.
• W2016045856 cites W1959628099 @default.
• W2016045856 cites W1968703754 @default.
• W2016045856 cites W1979714353 @default.
• W2016045856 cites W1995492403 @default.
• W2016045856 cites W2007131804 @default.
• W2016045856 cites W2029048154 @default.
• W2016045856 cites W2047631667 @default.
• W2016045856 cites W2059944898 @default.
• W2016045856 cites W2077597313 @default.
• W2016045856 cites W2084495605 @default.
• W2016045856 cites W2088446974 @default.
• W2016045856 cites W2092736872 @default.
• W2016045856 cites W2096287682 @default.
• W2016045856 cites W2097181552 @default.
• W2016045856 cites W2102099315 @default.
• W2016045856 cites W2105100844 @default.
• W2016045856 cites W2108151310 @default.
• W2016045856 cites W2112014411 @default.
• W2016045856 cites W2129289878 @default.
• W2016045856 cites W2136527161 @default.
• W2016045856 cites W2160494869 @default.
• W2016045856 cites W2162643152 @default.
• W2016045856 cites W2365629726 @default.
• W2016045856 doi "https://doi.org/10.1111/ene.12192" @default.
• W2016045856 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23679051" @default.
• W2016045856 hasPublicationYear "2013" @default.
• W2016045856 type Work @default.
• W2016045856 sameAs 2016045856 @default.
• W2016045856 citedByCount "44" @default.
• W2016045856 countsByYear W20160458562013 @default.
• W2016045856 countsByYear W20160458562014 @default.
• W2016045856 countsByYear W20160458562015 @default.
• W2016045856 countsByYear W20160458562016 @default.
• W2016045856 countsByYear W20160458562017 @default.
• W2016045856 countsByYear W20160458562018 @default.
• W2016045856 countsByYear W20160458562019 @default.
• W2016045856 countsByYear W20160458562021 @default.
• W2016045856 countsByYear W20160458562022 @default.
• W2016045856 countsByYear W20160458562023 @default.
• W2016045856 crossrefType "journal-article" @default.
• W2016045856 hasAuthorship W2016045856A5001037498 @default.
• W2016045856 hasAuthorship W2016045856A5004631664 @default.
• W2016045856 hasAuthorship W2016045856A5004669844 @default.
• W2016045856 hasAuthorship W2016045856A5005521408 @default.
• W2016045856 hasAuthorship W2016045856A5018786124 @default.
• W2016045856 hasAuthorship W2016045856A5023933895 @default.
• W2016045856 hasAuthorship W2016045856A5025936970 @default.
• W2016045856 hasAuthorship W2016045856A5039085121 @default.
• W2016045856 hasAuthorship W2016045856A5039346856 @default.
• W2016045856 hasAuthorship W2016045856A5048201812 @default.
• W2016045856 hasAuthorship W2016045856A5055506828 @default.
• W2016045856 hasAuthorship W2016045856A5086102127 @default.
• W2016045856 hasConcept C120665830 @default.
• W2016045856 hasConcept C121332964 @default.
• W2016045856 hasConcept C126322002 @default.
• W2016045856 hasConcept C141071460 @default.
• W2016045856 hasConcept C143998085 @default.
• W2016045856 hasConcept C167135981 @default.
• W2016045856 hasConcept C2776194525 @default.
• W2016045856 hasConcept C2777389519 @default.
• W2016045856 hasConcept C2989005 @default.
• W2016045856 hasConcept C502942594 @default.
• W2016045856 hasConcept C509974204 @default.
• W2016045856 hasConcept C61511704 @default.
• W2016045856 hasConcept C71924100 @default.
• W2016045856 hasConcept C72563966 @default.
• W2016045856 hasConceptScore W2016045856C120665830 @default.
• W2016045856 hasConceptScore W2016045856C121332964 @default.
• W2016045856 hasConceptScore W2016045856C126322002 @default.
• W2016045856 hasConceptScore W2016045856C141071460 @default.
• W2016045856 hasConceptScore W2016045856C143998085 @default.
• W2016045856 hasConceptScore W2016045856C167135981 @default.
• W2016045856 hasConceptScore W2016045856C2776194525 @default.
• W2016045856 hasConceptScore W2016045856C2777389519 @default.
• W2016045856 hasConceptScore W2016045856C2989005 @default.
• W2016045856 hasConceptScore W2016045856C502942594 @default.
• W2016045856 hasConceptScore W2016045856C509974204 @default.
• W2016045856 hasConceptScore W2016045856C61511704 @default.
• W2016045856 hasConceptScore W2016045856C71924100 @default.
• W2016045856 hasConceptScore W2016045856C72563966 @default.
• W2016045856 hasIssue "10" @default.

• next